SPRINT Regional Lab – Phoenix, AZ

Name: SPRINT Regional Lab – Phoenix, AZ
Start: 2024-06-01T00:00:00-04:00
End: 2024-06-01T23:59:59-04:00

June 1

The SPRINT PNS System regional training lab in Phoenix on June 1 is intended for interventional pain management physicians with appropriate pain patients and facility approval to use the SPRINT PNS System.

This lab is focused on ultrasound and fluoroscopic imaging and hands-on lead implantation procedure training using cadavers and anatomical models. Live model ultrasound imaging for nerve identification and didactic presentations provides comprehensive training for the SPRINT PNS System.

For information about any upcoming SPRINT training events, please contact us by emailing education@sprtherapeutics.com

Share this post:

X (Twitter) Facebook LinkedIn SMS Email

Details

Date:: June 1
Event Category:: Training Lab

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Share this post:

Details

SPR Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT PNS Treatment in Relieving Postoperative Knee Pain

Miami University Highlights Maria Bennett, President, CEO and Founder, for Leadership of a Top 50 Fastest Growing Private Company

Article Published Highlighting Sustained Relief of CRPS Pain Following Treatment with SPRINT^® PNS

SPR^® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT^® PNS System

SPRINT Regional Lab – Phoenix, AZ

June 1

Share this post:

Details

Related Events

SPRINT Regional Lab – Gainesville, FL

SPRINT Regional Lab – Dallas, TX

SPR Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT PNS Treatment in Relieving Postoperative Knee Pain

Miami University Highlights Maria Bennett, President, CEO and Founder, for Leadership of a Top 50 Fastest Growing Private Company

Article Published Highlighting Sustained Relief of CRPS Pain Following Treatment with SPRINT® PNS

SPR® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT® PNS System

Article Published Highlighting Sustained Relief of CRPS Pain Following Treatment with SPRINT^® PNS

SPR^® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT^® PNS System